Conning Inc’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $34.5M | Buy |
175,906
+2,644
| +2% | +$514K | 1.15% | 41 |
|
|
2025
Q4 | $30.1M | Buy |
+173,262
| New | +$31.5M | 1.01% | 57 |
|
|
2022
Q1 | – | Sell |
-1,514
| Closed | -$262K | – | 438 |
|
|
2021
Q4 | $262K | Sell |
1,514
-57
| -4% | -$8.67K | 0.01% | 377 |
|
|
2021
Q3 | $228K | Sell |
1,571
-170
| -10% | -$24.9K | 0.01% | 410 |
|
|
2021
Q2 | $230K | Sell |
1,741
-160
| -8% | -$20.9K | 0.01% | 439 |
|
|
2021
Q1 | $244K | Sell |
1,901
-160
| -8% | -$19.7K | 0.01% | 428 |
|
|
2020
Q4 | $246K | Sell |
2,061
-99
| -5% | -$12.1K | 0.01% | 417 |
|
|
2020
Q3 | $247K | Buy |
2,160
+20
| +0.9% | +$2.36K | 0.01% | 391 |
|
|
2020
Q2 | $244K | Buy |
+2,140
| New | +$227K | 0.01% | 387 |
|
|
2020
Q1 | – | Sell |
-2,261
| Closed | -$241K | – | 430 |
|
|
2019
Q4 | $241K | Buy |
2,261
+60
| +3% | +$6.26K | 0.01% | 431 |
|
|
2019
Q3 | $236K | Sell |
2,201
-90
| -4% | -$9.24K | 0.01% | 445 |
|
|
2019
Q2 | $233K | Sell |
2,291
-7,087
| -76% | -$681K | 0.01% | 454 |
|
|
2019
Q1 | $843K | Sell |
9,378
-10
| -0.1% | -$867 | 0.03% | 264 |
|
|
2018
Q4 | $782K | Sell |
9,388
-180
| -2% | -$16.9K | 0.03% | 267 |
|
|
2018
Q3 | $1.03M | Sell |
9,568
-335
| -3% | -$36.7K | 0.03% | 265 |
|
|
2018
Q2 | $1.09M | Sell |
9,903
-10
| -0.1% | -$1.04K | 0.03% | 273 |
|
|
2018
Q1 | $994K | Sell |
9,913
-670
| -6% | -$68.6K | 0.03% | 269 |
|
|
2017
Q4 | $1.04M | Buy |
10,583
+510
| +5% | +$48.3K | 0.03% | 274 |
|
|
2017
Q3 | $943K | Sell |
10,073
-10
| -0.1% | -$1.06K | 0.03% | 282 |
|
|
2017
Q2 | $1.12M | Sell |
10,083
-220
| -2% | -$23.3K | 0.04% | 267 |
|
|
2017
Q1 | $1.01M | Buy |
10,303
+90
| +0.9% | +$8.58K | 0.04% | 268 |
|
|
2016
Q4 | $939K | Sell |
10,213
-10
| -0.1% | -$862 | 0.04% | 274 |
|
|
2016
Q3 | $865K | Buy |
10,223
+120
| +1% | +$10.1K | 0.03% | 290 |
|
|
2016
Q2 | $822K | Buy |
10,103
+10
| +0.1% | +$761 | 0.03% | 282 |
|
|
2016
Q1 | $721K | Buy |
10,093
+110
| +1% | +$7.38K | 0.03% | 302 |
|
|
2015
Q4 | $710K | Sell |
9,983
-100
| -1% | -$6.72K | 0.03% | 306 |
|
|
2015
Q3 | $620K | Sell |
10,083
-420
| -4% | -$29.4K | 0.03% | 310 |
|
|
2015
Q2 | $762K | Sell |
10,503
-140
| -1% | -$10.3K | 0.03% | 306 |
|
|
2015
Q1 | $818K | Sell |
10,643
-20
| -0.2% | -$1.43K | 0.03% | 284 |
|
|
2014
Q4 | $715K | Sell |
10,663
-130
| -1% | -$8.2K | 0.03% | 314 |
|
|
2014
Q3 | $655K | Sell |
10,793
-220
| -2% | -$13.6K | 0.03% | 319 |
|
|
2014
Q2 | $646K | Sell |
11,013
-380
| -3% | -$22.3K | 0.03% | 318 |
|
|
2014
Q1 | $660K | Buy |
11,393
+100
| +0.9% | +$5.36K | 0.04% | 309 |
|
|
2013
Q4 | $605K | Buy |
11,293
+740
| +7% | +$43.9K | 0.04% | 297 |
|
|
2013
Q3 | $652K | Buy |
10,553
+190
| +2% | +$11.4K | 0.05% | 244 |
|
|
2013
Q2 | $628K | Buy |
+10,363
| New | +$617K | 0.05% | 236 |
|
Other funds holding DGX
VCM
VPM
EIG
Conning Inc's DGX Position: Q1 2026 in Review
Conning Inc increased its Quest Diagnostics (DGX) stake by 1.5% in Q1 2026, buying an estimated $514K and bringing the position to 175,906 shares worth $34.5M. The position accounts for 1.15% of the portfolio, ranked #41.
Conning Inc first reported a position in DGX in Q2 2013 and has held it in 36 quarters since. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Conning Inc held 175,906 shares of Quest Diagnostics worth $34.5M as of Q1 2026.
- Conning Inc bought 2,644 Quest Diagnostics shares in Q1 2026, an estimated $514K.
- Quest Diagnostics made up 1.15% of Conning Inc's portfolio in Q1 2026, its #41 holding.
- Conning Inc first reported a position in Quest Diagnostics in Q2 2013 and has held it in 36 quarters since.
- 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Conning Inc's 13F filing for Q1 2026, filed 30 Apr 2026.